Skip to main content
CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.80
-0.96 (-4.22%)
Apr 29, 2026, 4:08 PM HKT

HKG:2171 Revenue

In the year 2025, CARsgen Therapeutics Holdings had annual revenue of 125.66M CNY with 218.74% growth. CARsgen Therapeutics Holdings had revenue of 74.70M in the half year ending December 31, 2025.

Revenue
125.66M CNY
Revenue Growth
+218.74%
P/S Ratio
83.92
Revenue / Employee
353.98K CNY
Employees
355
Market Cap
11.74B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025125.66M86.24M218.74%
Dec 31, 202439.43M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 202125.81M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Everest Medicines 1.90B
HBM Holdings 1.23B
Alphamab Oncology 630.11M
CStone Pharmaceuticals 299.99M
Nanjing Leads Biolabs 197.25M
Lepu Biopharma 1.04B
Ascentage Pharma Group International 638.89M
Abbisko Cayman 681.17M
Revenue Rankings

CARsgen Therapeutics Holdings News

More News